Correlation Between Microsoft and Eyepoint Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Microsoft and Eyepoint Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Eyepoint Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Eyepoint Pharmaceuticals, you can compare the effects of market volatilities on Microsoft and Eyepoint Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Eyepoint Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Eyepoint Pharmaceuticals.
Diversification Opportunities for Microsoft and Eyepoint Pharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Microsoft and Eyepoint is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Eyepoint Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyepoint Pharmaceuticals and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Eyepoint Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyepoint Pharmaceuticals has no effect on the direction of Microsoft i.e., Microsoft and Eyepoint Pharmaceuticals go up and down completely randomly.
Pair Corralation between Microsoft and Eyepoint Pharmaceuticals
Given the investment horizon of 90 days Microsoft is expected to generate 0.22 times more return on investment than Eyepoint Pharmaceuticals. However, Microsoft is 4.6 times less risky than Eyepoint Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Eyepoint Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 42,615 in Microsoft on September 12, 2024 and sell it today you would earn a total of 2,284 from holding Microsoft or generate 5.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Microsoft vs. Eyepoint Pharmaceuticals
Performance |
Timeline |
Microsoft |
Eyepoint Pharmaceuticals |
Microsoft and Eyepoint Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Microsoft and Eyepoint Pharmaceuticals
The main advantage of trading using opposite Microsoft and Eyepoint Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Eyepoint Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyepoint Pharmaceuticals will offset losses from the drop in Eyepoint Pharmaceuticals' long position.Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |